NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Great Bay Bio

Great Bay Bio

Private
Hong KongHealthcare & Life Scienceshttps://www.greatbay-bio.com/

Last Round

Series B

Dec 16, 2024

Total Funding Raised

$28.8M

Company Overview

Great Bay Bio is a biotechnology company that develops AI-driven bioprocessing technology to accelerate biologic drug discovery, cell line engineering, and manufacturing preparation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

CDMObiopharmaceutical manufacturingcell line developmentCLDbiologicsAI-driven drug discoveryGMP manufacturingbiotech AIprocess developmentdrug development servicesin silico drug designAI-native biotechmedia formulationoutsourced R&Dantibody design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Great Bay Bio Comps

Public and private peers based on sector, stage, and business model.

Great Bay Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Great Bay Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 16, 2024
Series BSep 13, 2022
Series ADec 1, 2021
Convertible DebtFeb 23, 2021

Key People

Founding team and executive leadership

Michael Chen

CEO

Executive Team

Kenneth Lai

Chief Financial Officer

Executive Team

Great Bay Bio Investors

Notable investors and investment history

Great Bay Bio investors
InvestorRounds
Vectr VenturesSeries B
Tiger Jade CapitalSeries B
FutureX CapitalSeries A
PentepebbleSeries B
高瓴创投Series A
Proxima Ventures Ltd.Series A
Gobi Partners GBASeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2021

    $10M round led by Proxima Ventures Ltd.

Great Bay Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Great Bay Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Great Bay Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersHong Kong
Employee Range33
Year Founded2019
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.